Why A Gene Therapy Pioneer Is Raising Concerns About Treatments He Championed – Forbes
Forbes |
Why A Gene Therapy Pioneer Is Raising Concerns About Treatments He Championed
Forbes It's a hard won expertise. In 1999, when it seemed that gene therapy was on the cusp of becoming a reality, a patient in a study Wilson was running died. The memory of that young man, 18-year-old Jesse Gelsinger, has motivated him to find better … |
